Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Oxycodone Assay Added to Drugs of Abuse Test Menu

By LabMedica International staff writers
Posted on 29 Apr 2009
A drug of abuse test menu has been expanded to include an oxycodone enzyme immunoassay. More...
The assay is for the qualitative and semiquantitative determination of oxycodone and its metabolite, oxymorphone, in human urine.

Reagents and calibrators for the oxycodone assay are liquid and ready-to-use, which eliminates the need for mixing, hydrating, or prediluting reagents before testing.

Drugs of Abuse Test (DAT) assays are available through Beckman Coulter (Nyon, Switzerland) They are specifically engineered, formulated, and packaged to provide the critical elements of effective DAT analysis--speed, accuracy, ease-of-use, and economy. The assays, when used in conjunction with Synchron and UniCel clinical chemistry systems, provide timely, reliable and efficient DAT results.

Oxycodone is a semisynthetic opioid prescribed for pain management in patients with moderate to severe pain. This narcotic pain reliever is similar to codeine and morphine in its analgesic properties, but is more potent than morphine and has greater potential for dependence. It is supplied as OxyContin (Oxycodone HCI), or in combination with aspirin (Percodan) or acetaminophen (Percocet). The pills are often crushed into a powder and inhaled for a faster effect, which can have a fatal outcome.

Related Links:
Beckman Coulter



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Immunofluorescence Analyzer
IFA System
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.